NasdaqGS - Delayed Quote USD
Alector, Inc. (ALEC)
1.0200
-0.0300
(-2.86%)
At close: May 7 at 4:00:01 PM EDT
1.0600
+0.04
+(3.92%)
After hours: May 7 at 4:42:54 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 5 | 6 |
| Avg. Estimate | -0.46 | -0.48 | -1.97 | -1.34 |
| Low Estimate | -0.53 | -0.55 | -2.16 | -2.14 |
| High Estimate | -0.41 | -0.41 | -1.63 | -0.08 |
| Year Ago EPS | -0.38 | -0.4 | -1.23 | -1.97 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 7 | 7 |
| Avg. Estimate | 4.25M | 4.25M | 14.12M | 59.48M |
| Low Estimate | 2.5M | 2.5M | 9.38M | 3.61M |
| High Estimate | 6M | 6M | 24M | 200.83M |
| Year Ago Sales | 15.89M | 15.08M | 100.56M | 14.12M |
| Sales Growth (year/est) | -73.26% | -71.82% | -85.95% | 321.09% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.49 | -0.48 | -0.53 | -0.54 |
| EPS Actual | -0.38 | -0.4 | -0.43 | -0.02 |
| Difference | 0.11 | 0.08 | 0.1 | 0.52 |
| Surprise % | 22.45% | 17.24% | 18.85% | 96.33% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.46 | -0.48 | -1.97 | -1.34 |
| 7 Days Ago | -0.46 | -0.48 | -1.98 | -1.32 |
| 30 Days Ago | -0.45 | -0.44 | -1.71 | -1.12 |
| 60 Days Ago | 0.12 | -0.52 | -1.54 | -1.12 |
| 90 Days Ago | 0.07 | -0.45 | -1.29 | -1.11 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 1 | -- |
| Up Last 30 Days | 1 | 1 | 3 | -- |
| Down Last 7 Days | 1 | 1 | -- | 1 |
| Down Last 30 Days | 2 | 2 | 1 | 3 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ALEC | -21.05% | -20.62% | -60.49% | 32.37% |
| S&P 500 | 12.50% | 3.24% | 7.95% | 13.84% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 2/27/2025 |
| Downgrade | Stifel: Buy to Hold | 12/16/2024 |
| Downgrade | Morgan Stanley: Equal-Weight to Underweight | 11/26/2024 |
| Maintains | BTIG: Buy to Buy | 11/26/2024 |
| Reiterates | Cantor Fitzgerald: Overweight | 11/26/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 11/7/2024 |
Related Tickers
STOK Stoke Therapeutics, Inc.
8.66
-1.03%
DNLI Denali Therapeutics Inc.
14.32
+2.51%
YMAB Y-mAbs Therapeutics, Inc.
3.8800
+0.52%
GOSS Gossamer Bio, Inc.
1.0950
+0.46%
CMMB Chemomab Therapeutics Ltd.
1.2300
+0.82%
CGEM Cullinan Therapeutics, Inc.
7.70
-1.91%
EWTX Edgewise Therapeutics, Inc.
14.52
+0.97%
DAWN Day One Biopharmaceuticals, Inc.
6.30
-9.87%
INZY Inozyme Pharma, Inc.
1.3300
+5.56%
ACRV Acrivon Therapeutics, Inc.
1.2300
-7.52%